Artivion (AORT) Income towards Parent Company (2010 - 2026)
Artivion (AORT) posted Income towards Parent Company of $1.4 million for Q1 2026, down 41.59% on a QoQ basis from $2.4 million in Q4 2025, and up 380.59% year-over-year from $294843.4 in Q1 2025.
Artivion (AORT) Income towards Parent Company (2010 - 2026) Analysis & Trends
Artivion's Income towards Parent Company history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- Quarterly Income towards Parent Company rose 380.59% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 154.63% YoY) and the FY2025 annual result came in at $9.8 million, up 173.12% from the prior year.
- Income towards Parent Company was $1.4 million for Q1 2026 at Artivion, down from $2.4 million in the prior quarter.
- Across five years, Income towards Parent Company topped out at $7.5 million in Q1 2024 and bottomed at -$16.5 million in Q4 2024.
- A 5-year average of -$3.1 million and a median of -$2.3 million in 2024 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2024 — Income towards Parent Company slumped 314.67% — and 2025, when it soared 384.18%.
- Artivion's Income towards Parent Company stood at $2.2 million in 2022, then slumped by 283.26% to -$4.0 million in 2023, then slumped by 314.67% to -$16.5 million in 2024, then jumped by 114.72% to $2.4 million in 2025, then slumped by 41.59% to $1.4 million in 2026.
- Business Quant data shows AORT's Income towards Parent Company at $1.4 million in Q1 2026, $2.4 million in Q4 2025, and $6.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn |
| 10 | Artivion | 1.25 Bn | 1.20 Bn | 75.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Mar 31, 2025 | -505,000.00 |
| Dec 31, 2024 | -16.48 Mn |
| Sep 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.12 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | -3.98 Mn |
| Sep 30, 2023 | -9.80 Mn |
| Jun 30, 2023 | -3.38 Mn |
| Mar 31, 2023 | -13.53 Mn |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | -13.71 Mn |
| Jun 30, 2022 | -4.26 Mn |
| Mar 31, 2022 | -3.39 Mn |
| Dec 31, 2021 | -20.10 Mn |
| Sep 30, 2021 | 10.58 Mn |
| Jun 30, 2021 | -2.18 Mn |